[ad_1] – Final European Commission decision expected within 67 days after positive opinion; if approved, first European Union launch planned in Germany in early 2024 COPENHAGEN, Denmark, Sept. 14, 2023…
Tag: palopegteriparatide
Ascendis Pharma Opens Compassionate Use Program for TransCon™ PTH (palopegteriparatide) in Germany
[ad_1] Ascendis Pharma Opens Compassionate Use Program for … Kentucky Today [ad_2] Source link